A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.


Journal

European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752

Informations de publication

Date de publication:
17 10 2019
Historique:
received: 16 05 2019
accepted: 21 08 2019
entrez: 19 10 2019
pubmed: 19 10 2019
medline: 18 9 2020
Statut: epublish

Résumé

To develop a supervised machine learning (ML) algorithm predicting above- versus below-median overall survival (OS) from diffusion-weighted imaging-derived radiomic features in patients with pancreatic ductal adenocarcinoma (PDAC). One hundred two patients with histopathologically proven PDAC were retrospectively assessed as training cohort, and 30 prospectively accrued and retrospectively enrolled patients served as independent validation cohort (IVC). Tumors were segmented on preoperative apparent diffusion coefficient (ADC) maps, and radiomic features were extracted. A random forest ML algorithm was fit to the training cohort and tested in the IVC. Histopathological subtype of tumor samples was assessed by immunohistochemistry in 21 IVC patients. Individual radiomic feature importance was evaluated by assessment of tree node Gini impurity decrease and recursive feature elimination. Fisher's exact test, 95% confidence intervals (CI), and receiver operating characteristic area under the curve (ROC-AUC) were used. The ML algorithm achieved 87% sensitivity (95% IC 67.3-92.7), 80% specificity (95% CI 74.0-86.7), and ROC-AUC 90% for the prediction of above- versus below-median OS in the IVC. Heterogeneity-related features were highly ranked by the model. Of the 21 patients with determined histopathological subtype, 8/9 patients predicted to experience below-median OS exhibited the quasi-mesenchymal subtype, whilst 11/12 patients predicted to experience above-median OS exhibited a non-quasi-mesenchymal subtype (p < 0.001). ML application to ADC radiomics allowed OS prediction with a high diagnostic accuracy in an IVC. The high overlap of clinically relevant histopathological subtypes with model predictions underlines the potential of quantitative imaging in PDAC pre-operative subtyping and prognosis.

Sections du résumé

BACKGROUND
To develop a supervised machine learning (ML) algorithm predicting above- versus below-median overall survival (OS) from diffusion-weighted imaging-derived radiomic features in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS
One hundred two patients with histopathologically proven PDAC were retrospectively assessed as training cohort, and 30 prospectively accrued and retrospectively enrolled patients served as independent validation cohort (IVC). Tumors were segmented on preoperative apparent diffusion coefficient (ADC) maps, and radiomic features were extracted. A random forest ML algorithm was fit to the training cohort and tested in the IVC. Histopathological subtype of tumor samples was assessed by immunohistochemistry in 21 IVC patients. Individual radiomic feature importance was evaluated by assessment of tree node Gini impurity decrease and recursive feature elimination. Fisher's exact test, 95% confidence intervals (CI), and receiver operating characteristic area under the curve (ROC-AUC) were used.
RESULTS
The ML algorithm achieved 87% sensitivity (95% IC 67.3-92.7), 80% specificity (95% CI 74.0-86.7), and ROC-AUC 90% for the prediction of above- versus below-median OS in the IVC. Heterogeneity-related features were highly ranked by the model. Of the 21 patients with determined histopathological subtype, 8/9 patients predicted to experience below-median OS exhibited the quasi-mesenchymal subtype, whilst 11/12 patients predicted to experience above-median OS exhibited a non-quasi-mesenchymal subtype (p < 0.001).
CONCLUSION
ML application to ADC radiomics allowed OS prediction with a high diagnostic accuracy in an IVC. The high overlap of clinically relevant histopathological subtypes with model predictions underlines the potential of quantitative imaging in PDAC pre-operative subtyping and prognosis.

Identifiants

pubmed: 31624935
doi: 10.1186/s41747-019-0119-0
pii: 10.1186/s41747-019-0119-0
pmc: PMC6797674
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41

Références

Radiology. 2018 Jun;287(3):864-873
pubmed: 29393821
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Clin Cancer Res. 2008 Jan 15;14(2):412-8
pubmed: 18223216
Front Oncol. 2015 Dec 03;5:272
pubmed: 26697407
BMC Med Imaging. 2017 Jun 19;17(1):38
pubmed: 28629416
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
PLoS One. 2019 Jan 18;14(1):e0210758
pubmed: 30657785
JCO Precis Oncol. 2018;2018:null
pubmed: 30506016
PLoS One. 2014 Mar 03;9(3):e89468
pubmed: 24594702
Clin Cancer Res. 2018 Mar 15;24(6):1344-1354
pubmed: 29288237
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Sci Rep. 2017 Dec 6;7(1):17038
pubmed: 29213099
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1143-1158
pubmed: 30170872
Magn Reson Imaging. 2014 Feb;32(2):125-31
pubmed: 24231348
Nat Med. 2011 Apr;17(4):500-3
pubmed: 21460848
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Clin Cancer Res. 2019 Jan 15;25(2):584-594
pubmed: 30397175
Nat Rev Cancer. 2017 Apr;17(4):239-253
pubmed: 28256574
Clin Cancer Res. 2017 Mar 15;23(6):1461-1470
pubmed: 27663591
Clin Cancer Res. 2018 Jan 15;24(2):351-359
pubmed: 29101303
Nature. 2018 Feb 1;554(7690):62-68
pubmed: 29364867
Sci Rep. 2019 Mar 18;9(1):4800
pubmed: 30886309
Korean J Radiol. 2015 Nov-Dec;16(6):1216-25
pubmed: 26576110

Auteurs

Georgios Kaissis (G)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, DE-81675, Munich, Germany.

Sebastian Ziegelmayer (S)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, DE-81675, Munich, Germany.

Fabian Lohöfer (F)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, DE-81675, Munich, Germany.

Hana Algül (H)

Department of Internal Medicine II, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Matthias Eiber (M)

Department of Nuclear Medicine, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Wilko Weichert (W)

Department of Pathology, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Roland Schmid (R)

Department of Internal Medicine II, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Helmut Friess (H)

Department of Surgery, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Ernst Rummeny (E)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, DE-81675, Munich, Germany.

Donna Ankerst (D)

Department of Mathematics, Technical University of Munich, Garching, Germany.

Jens Siveke (J)

West German Cancer Center, University of Essen, Essen, Germany.

Rickmer Braren (R)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, DE-81675, Munich, Germany. rbraren@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH